Patent classifications
A01N63/40
Bioassisted treatment of microbiologically influenced corrosion in petroleum transporting pipelines
The present invention relates to a method for reducing or preventing the formation or activity of a corrosion-associated biofilm on a metal surface, wherein the method comprises contacting the metal surface with a liquid composition comprising biocidal preparation. The present invention also relates to a microbicidal composition comprising at least one alcohol, one liquid hydrocarbon, a bacteriophage immobilized on a magnetic nanocomposite, at least one phage releasing reagent and one stabilizer. The microbicide composition and method of the present invention reduces biofilms on surfaces, and consequently, reduces, mitigates, or eliminates MIC in internal surface of the oil transporting pipelines.
Bioassisted treatment of microbiologically influenced corrosion in petroleum transporting pipelines
The present invention relates to a method for reducing or preventing the formation or activity of a corrosion-associated biofilm on a metal surface, wherein the method comprises contacting the metal surface with a liquid composition comprising biocidal preparation. The present invention also relates to a microbicidal composition comprising at least one alcohol, one liquid hydrocarbon, a bacteriophage immobilized on a magnetic nanocomposite, at least one phage releasing reagent and one stabilizer. The microbicide composition and method of the present invention reduces biofilms on surfaces, and consequently, reduces, mitigates, or eliminates MIC in internal surface of the oil transporting pipelines.
METHOD, COMPRISING BACTERIOPHAGES, FOR REDUCING THE POPULATION OF AT LEAST ONE ADIPOGENIC BACTERIAL SPECIES, AND BACTERIOPHAGES AND THE USE THEREOF
A method for reducing the population of at least one adipogenic bacteria species, the method comprising the following steps: a) providing a biologic sample which comprises at least one adipogenic bacteria species; and b) providing bacteriophages of at least one bacteriophage species which are specific to at least one adipogenic bacteria species and comprise at least one nucleic acid functionally bound to a promoter and/or to a regulatory element; and c) exposing the biologic sample to and incubating it with the bacteriophages, incubation taking place until the population of the adiopogenic bacteria species has been reduced by at least 70%; as well as relating to bacteriophages and their use.
COMPOSITION COMPRISING MULTIPLE BACULOVIRUSES TO TARGET DIFFICULT INSECT SPECIES
The present invention relates to an agricultural composition comprising at least three insect pathogenic viruses, selected from Autographica californica (Alfalfa Looper) multiple nucleopolyhedrovirus (AcMNPV), Helicoverpa armigera nucleopolyhedrosis virus (HaNPV), Plutella xylostella granulovirus (PxGV), Spodoptera litura (oriental leafworm moth) nucleopolyhedrovirus (SpltNPV) and Spodoptera exigua (beet armyworm) nucleopolyhedrovirus (SeNPV).
COMPOSITION COMPRISING MULTIPLE BACULOVIRUSES TO TARGET DIFFICULT INSECT SPECIES
The present invention relates to an agricultural composition comprising at least three insect pathogenic viruses, selected from Autographica californica (Alfalfa Looper) multiple nucleopolyhedrovirus (AcMNPV), Helicoverpa armigera nucleopolyhedrosis virus (HaNPV), Plutella xylostella granulovirus (PxGV), Spodoptera litura (oriental leafworm moth) nucleopolyhedrovirus (SpltNPV) and Spodoptera exigua (beet armyworm) nucleopolyhedrovirus (SeNPV).
COMPOSITION COMPRISING MULTIPLE BACULOVIRUSES TO TARGET DIFFICULT INSECT SPECIES
The present invention relates to an agricultural composition comprising at least three insect pathogenic viruses, selected from Autographica californica (Alfalfa Looper) multiple nucleopolyhedrovirus (AcMNPV), Helicoverpa armigera nucleopolyhedrosis virus (HaNPV), Plutella xylostella granulovirus (PxGV), Spodoptera litura (oriental leafworm moth) nucleopolyhedrovirus (SpltNPV) and Spodoptera exigua (beet armyworm) nucleopolyhedrovirus (SeNPV).
NOVEL LACTOBACILLUS BREVIS BACTERIOPHAGE LAC-BRP-1 AND USE THEREOF FOR INHIBITING LACTOBACILLUS BREVIS PROLIFERATION
The present invention relates to a Siphoviridae bacteriophage Lac-BRP-1 that is isolated from the nature and can kill Lactobacillus brevis cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12659BP), and a method for preventing and treating the contaminations of Lactobacillus brevis by using the composition comprising the bacteriophage as an active ingredient.
NEW USES OF A MUTATED LACTONASE, AND COMPOSITIONS
Disclosed is a mutated lactonase belonging to the phosphotriesterase-like lactonase family, which increases the susceptibility of bacteria to antimicrobial agents as compared to the use of antimicrobial agents alone.
NEW USES OF A MUTATED LACTONASE, AND COMPOSITIONS
Disclosed is a mutated lactonase belonging to the phosphotriesterase-like lactonase family, which increases the susceptibility of bacteria to antimicrobial agents as compared to the use of antimicrobial agents alone.
NOVEL ENTEROPATHOGENIC E. COLI BACTERIOPHAGE ESC-CHP-2 AND USE THEREOF FOR INHIBITING PROLIFERATION OF ENTEROPATHOGENIC E. COLI
The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.